These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29374532)

  • 1. Protein folding, misfolding and aggregation: A tale of constructive to destructive assembly.
    Khan MV; Zakariya SM; Khan RH
    Int J Biol Macromol; 2018 Jun; 112():217-229. PubMed ID: 29374532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and Functions of Spatial Protein Quality Control.
    Sontag EM; Samant RS; Frydman J
    Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloidogenicity of p53: a hidden link between protein misfolding and cancer.
    Gong H; Yang X; Zhao Y; Petersen RB; Liu X; Liu Y; Huang K
    Curr Protein Pept Sci; 2015; 16(2):135-46. PubMed ID: 25692950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
    Zaman M; Khan AN; Wahiduzzaman ; Zakariya SM; Khan RH
    Int J Biol Macromol; 2019 Aug; 134():1022-1037. PubMed ID: 31128177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates.
    Ilie IM; Caflisch A
    Chem Rev; 2019 Jun; 119(12):6956-6993. PubMed ID: 30973229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPAD, Curated Protein Aggregation Database: A Repository of Manually Curated Experimental Data on Protein and Peptide Aggregation.
    Thangakani AM; Nagarajan R; Kumar S; Sakthivel R; Velmurugan D; Gromiha MM
    PLoS One; 2016; 11(4):e0152949. PubMed ID: 27043825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.
    Cheng B; Gong H; Xiao H; Petersen RB; Zheng L; Huang K
    Biochim Biophys Acta; 2013 Oct; 1830(10):4860-71. PubMed ID: 23820032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrogating Amyloid Aggregates using Fluorescent Probes.
    Aliyan A; Cook NP; Martí AA
    Chem Rev; 2019 Dec; 119(23):11819-11856. PubMed ID: 31675223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of water in protein folding, oligomerization, amyloidosis and miniprotein.
    Vajda T; Perczel A
    J Pept Sci; 2014 Oct; 20(10):747-59. PubMed ID: 25098401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Misfolding Diseases.
    Hartl FU
    Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When proteostasis goes bad: Protein aggregation in the cell.
    Radwan M; Wood RJ; Sui X; Hatters DM
    IUBMB Life; 2017 Feb; 69(2):49-54. PubMed ID: 28066979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical and Spectroscopic Methods for Monitoring Protein Misfolding and Amyloid Aggregation.
    Cristóvão JS; Henriques BJ; Gomes CM
    Methods Mol Biol; 2019; 1873():3-18. PubMed ID: 30341600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of Heterotypic Amyloids: α-Synuclein in Co-Aggregation.
    Bhasne K; Mukhopadhyay S
    Proteomics; 2018 Nov; 18(21-22):e1800059. PubMed ID: 30216674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling protein aggregation as an ageing related process or a neuropathological response.
    Trigo D; Nadais A; da Cruz E Silva OAB
    Ageing Res Rev; 2019 May; 51():67-77. PubMed ID: 30763619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
    Chiti F; Dobson CM
    Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies.
    Salahuddin P; Khan RH; Furkan M; Uversky VN; Islam Z; Fatima MT
    Int J Biol Macromol; 2021 Sep; 186():580-590. PubMed ID: 34271045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Reciprocity of Amyloids and Antimicrobial Peptides: Rethinking the Role of Supramolecular Assembly in Host Defense, Immune Activation, and Inflammation.
    Lee EY; Srinivasan Y; de Anda J; Nicastro LK; Tükel Ç; Wong GCL
    Front Immunol; 2020; 11():1629. PubMed ID: 32849553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the effect of macromolecular crowding on aggregation behaviour of a model amyloidogenic Peptide.
    Gaharwar B; Gour S; Kaushik V; Gupta N; Kumar V; Hause G; Yadav JK
    Protein Pept Lett; 2015; 22(1):87-93. PubMed ID: 25267253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.